The report presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Toxoplasmosis definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Toxoplasmosis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 226 pages and 15 tables

Table Of Contents

Table of Contents

I. Introduction
II. Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs Abbott AxSYM Abbott IMx/IMx Select Anagen AN2000/AuraFlex Beckman Coulter Access BioChem Pharma/SR1 BioMerieux/Vitek Vidas Biotrol System 7000 Chiron ACS: Centaur Chiron ACS: 180 JandJ Diagnostics/Amersham Amerlite JandJ Diagnostics Vitros ECi Olympus PK310 Roche Cobas Core Roche Elecsys 1010/2010 Roche ES 22 Roche ES 33 Roche ES 300/300AL Siemens ELISA Processor II/III Siemens Immuno 1 Siemens/Opus/Plus/Magnum Siemens Stratus Tosoh AIA-1200/1200DX/NexIA/600 Wallac/Pharmacia Delfia
E. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods Polymerase Chain Reaction
- Robotics
- Temperature Cyclers
- PCR Variations Immuno-PCR QC-PCR DAP-PCR Ligase Chain Reaction Branched DNA Q-Beta Replicase Nucleic-Acid Sequence-Based Strand Displacement Activation Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA) Overview ELISA Dot Immunobinding Assays Capillary Immunoassays Particle-Membrane Capture Immunoassays Enzyme Amplification
c. Fluorescent Immunoassays Fluorescence Polarization Time-Resolved Pulse Fluorescence
d. Luminescence Chemiluminescence Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
III. France: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
V. Italy: Test Market Size, Growth and Major Suppliers’
Sales and Market Shares
VI. Japan: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
VIII. UK: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
IX. USA: Market Size, Growth and Major Suppliers’ Sales
and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- DiaSorin
- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- JandJ
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosho
- Trinity Biotech
- Tropix
- Wampole Labs
- Zenith
- Zeus

List of Tables
Major Companies Developing or Marketing Toxoplasmosis
Tests
France
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by
Market Segment
France
Toxoplasmosis Testing Market Diagnostics Sales by
Major Supplier
Germany
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by
Market Segment
Germany
Toxoplasmosis Testing Market Diagnostics Sales by Major
Supplier
Italy
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by
Market Segment
Italy
Toxoplasmosis Testing Market Diagnostics Sales by
Major Supplier
Japan
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Toxoplasmosis Testing Market Diagnostics Sales by
Major Supplier
Spain
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by
Market Segment
Spain
Toxoplasmosis Testing Market Diagnostics Sales by
Major Supplier
U.K.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Toxoplasmosis Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Toxoplasmosis Testing Market Diagnostics Sales by
Major Supplier

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

  • $ 34 500
  • Industry report
  • July 2014
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 800
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of majo ...

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.